J. Goldman & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

J. Goldman & Co’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-76,900	Closed	-$13.3M	–	395
2015 Q1	$13.3M	Buy	76,900 +71,400	+1,298%	+$10.5M	0.82%	29
2014 Q4	$632K	Buy	5,500 +3,000	+120%	+$363K	0.07%	161
2014 Q3	$391K	Buy	+2,500	New	+$362K	0.02%	252

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

J. Goldman & Co's SLXP Position: Q2 2015 in Review

J. Goldman & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 76,900 shares — an estimated $13.3M sold.

J. Goldman & Co first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $13.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

J. Goldman & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
J. Goldman & Co sold 76,900 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $13.3M.
J. Goldman & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
J. Goldman & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $13.3M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on J. Goldman & Co's 13F filing for Q2 2015, filed 14 Aug 2015.